Baudax Bio
Troy Biehl has extensive work experience in the pharmaceutical industry. Troy currently holds the position of Key Account Manager at Ferring Pharmaceuticals since August 2022. Prior to this, they worked as a Regional Business Director - West at Baudax Bio starting from May 2020.
From 2017 to 2020, Troy was the Thrombosis Area Manager for Portola Pharmaceuticals- Andexxa. Troy also served as a Hospital Sales Specialist at Cadence Pharmaceuticals from November 2010 to July 2018.
Before joining Cadence Pharmaceuticals, Troy worked as a Hospital Sales Specialist at Mallinckrodt Pharmaceuticals from February 2014 to July 2017. Troy also gained experience as a Hospital Sales Specialist at Schering-Plough Pharmaceuticals for the period from 2007 to 2010.
Troy started their pharmaceutical career at organon in 2000 as a sales representative and continued in the same role when organon merged with Organon Pharmaceuticals from 2001 to 2007.
Troy Biehl attended California State University, Long Beach from 1994 to 1997, where they earned a Bachelor of Arts degree in kinesiology.
This person is not in any offices
Baudax Bio
Baudax Bio is a revenue-generating, specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings. The Company has multiple non-opioid therapeutics in clinical development for the treatment of pain conditions and is currently promoting their lead product, ANJESO™, indicated for use in adults for the management of moderate-to-severe pain, alone or in combination with non-NSAID analgesics.